In a perfect democracy, at least 50% of people would support every decision.

The U.S. falls short of this goal.

Activate to continue

Spoken For.
House vote: H.R. 1734 // May 11, 2023Needed two-thirds to pass

TRANQ Research Act of 2023

Sponsor: Mike Collins (R-GA)

Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023 or the TRANQ Research Act of 2023 This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. , a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhance relevant narcotic and opioid detection and analysis capabilities. Additionally, the Government Accountability Office must conduct a study on the capabilities of the federal government to detect, identify, and otherwise respond to threats of new psychoactive substances, such as xylazine.

Science, Technology, Communications Topic assigned by the Congressional Research Service.

Who won, and how much of the country was behind them

Won the vote · Yea

425 votes, representing 255,680,333 people97.7%of U.S. adults

Lost the vote · Nay

0 votes, representing 0 people0.0%of U.S. adults

The dotted gap is 2.3% of U.S. adults whose member did not vote, voted “present,” or whose seat was vacant.

Share of U.S. adults represented, the House
SideOutcomeVotesShare of U.S. adults
YeaWon42597.7%
NayLost00.0%
Not represented on this questionNo position taken02.3%